Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 1.13% | $141.77M | $391.52B | 45.90% | 81 Outperform | |
| Roche Holding AG | 1.03% | $128.30M | CHF253.59B | 44.17% | 73 Outperform | |
| AstraZeneca | 1.00% | $124.73M | £210.13B | 32.25% | 80 Outperform | |
| HSBC Holdings | 0.99% | $123.94M | HK$2.04T | 51.21% | 80 Outperform | |
| Nestlé SA | 0.93% | $116.30M | CHF200.57B | 18.60% | 71 Outperform | |
| Royal Bank Of Canada | 0.91% | $113.80M | $231.55B | 39.61% | 75 Outperform | |
| Shell (UK) | 0.91% | $113.34M | £151.64B | 10.66% | 73 Outperform | |
| SAP SE | 0.75% | $93.89M | €241.65B | -10.98% | 66 Neutral | |
| Novartis | 0.71% | $88.60M | $258.62B | 39.78% | 80 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 0.70% | $87.57M | €314.01B | -0.16% | 78 Outperform |